Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities
- PMID: 30115614
- PMCID: PMC6195447
- DOI: 10.1183/13993003.00246-2018
Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities
Abstract
Despite evidence that transmission is driving an extensively drug-resistant TB (XDR-TB) epidemic, our understanding of where and between whom transmission occurs is limited. We sought to determine whether there was genomic evidence of transmission between individuals without an epidemiologic connection.We conducted a prospective study of XDR-TB patients in KwaZulu-Natal, South Africa, during the 2011-2014 period. We collected sociodemographic and clinical data, and identified epidemiologic links based on person-to-person or hospital-based connections. We performed whole-genome sequencing (WGS) on the Mycobacterium tuberculosis isolates and determined pairwise single nucleotide polymorphism (SNP) differences.Among 404 participants, 123 (30%) had person-to-person or hospital-based links, leaving 281 (70%) epidemiologically unlinked. The median SNP difference between participants with person-to-person and hospital-based links was 10 (interquartile range (IQR) 8-24) and 16 (IQR 10-23), respectively. The median SNP difference between unlinked participants and their closest genomic link was 5 (IQR 3-9) and half of unlinked participants were within 7 SNPs of at least five participants.The majority of epidemiologically-unlinked XDR-TB patients had low pairwise SNP differences with at least one other participant, consistent with transmission. These data suggest that much of transmission may result from casual contact in community settings between individuals not known to one another.
Copyright ©ERS 2018.
Conflict of interest statement
Conflict of interest: None declared.
Figures
References
-
- Global Tuberculosis Report. WHO, 2017.
-
- Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ Jr., Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory medicine 2017. - PubMed
-
- Gandhi NR, Weissman D, Moodley P, Ramathal M, Elson I, Kreiswirth BN, Mathema B, Shashkina E, Rothenberg R, Moll AP, Friedland G, Sturm AW, Shah NS. Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. J Infect Dis 2013: 207(1): 9–17. - PMC - PubMed
-
- Becerra MC, Appleton SC, Franke MF, Chalco K, Arteaga F, Bayona J, Murray M, Atwood SS, Mitnick CD. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet 2011: 377(9760): 147–152. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 HL116271/HL/NHLBI NIH HHS/United States
- U19 AI111211/AI/NIAID NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- K23 AI134182/AI/NIAID NIH HHS/United States
- P30 AI051519/AI/NIAID NIH HHS/United States
- R01 AI138646/AI/NIAID NIH HHS/United States
- R01 AI089349/AI/NIAID NIH HHS/United States
- UL1 TR001073/TR/NCATS NIH HHS/United States
- R01 AI087465/AI/NIAID NIH HHS/United States
- K24 AI114444/AI/NIAID NIH HHS/United States
- P30 AI124414/AI/NIAID NIH HHS/United States
- K23 AI083088/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources